Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 1993 | 2014 | ||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
phenotype | 0.220 | None | 1.000 | 1 | 0 | 2004 | 2007 | ||||||||
|
surfactant protein A1 | 0.546 | 0.808 | 3.7E-04 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2001 | 2006 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2007 | 2012 | ||||||||
|
surfactant protein D | 0.500 | 0.846 | 7.5E-05 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2001 | 2008 | ||||||||
|
platelet derived growth factor receptor beta | 0.416 | 0.846 | 0.90 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
platelet derived growth factor receptor alpha | 0.415 | 0.808 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
phospholipase C delta 1 | 0.636 | 0.577 | 1.7E-19 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
surfactant protein B | 0.575 | 0.654 | 2.6E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
surfactant protein C | 0.556 | 0.692 | 7.5E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
bone morphogenetic protein 4 | 0.422 | 0.808 | 0.96 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
cellular communication network factor 4 | 0.554 | 0.692 | 6.4E-07 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
BCL2 interacting protein 3 | 0.520 | 0.731 | 2.0E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1991 | 1991 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
TIMP metallopeptidase inhibitor 1 | 0.380 | 0.885 | 0.50 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
alpha tocopherol transfer protein | 0.612 | 0.577 | 1.4E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
Fas associated via death domain | 0.537 | 0.846 | 0.53 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
CASP8 and FADD like apoptosis regulator | 0.485 | 0.846 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
cytochrome b | 0.529 | 0.808 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | |||||||||
|
metallothionein 3 | 0.582 | 0.615 | 6.4E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
podoplanin | 0.470 | 0.769 | 3.2E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 |